Improved Understanding of Genomics Drives Excitement in High-Grade Meningiomas
OncLive,
Priscilla Kaliopi Brastianos, MD At present, there are no FDA-approved systemic therapies for patients with high-grade…
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations
Overview of attention for article published in Journal of Clinical Oncology, October 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
Above-average Attention Score compared to outputs of the same age and source (60th percentile)
Readers on
- mendeley
- 40 Mendeley